SCHEMBL3353911

SCHEMBL3353911

CN1CCN(C(=O)C(=O)c2cn(C)c3ccc([N+](=O)[O-])cc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HRH4 Q9H3N8 2/20 0.45
▸ FAAH O00519 1/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ LMNA P02545 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3358211 0.92 MAPT (0.47) ALDH1A1HPGDKMT2ALMNAPOLB
SCHEMBL3351542 0.91 ALDH1A1 (0.46) ALDH1A1HPGDKMT2ALMNAPOLB
SCHEMBL3358890 0.89 POLB (0.52) ALDH1A1L3MBTL1LMNAPOLBGAA
SCHEMBL2075770 0.82 POLB (0.47) ALDH1A1HPGDKMT2ALMNAPOLB
SCHEMBL7508094 0.80 CDK2 (0.46) L3MBTL1KMT2ALMNAPOLBMEN1
SCHEMBL13537346 0.79 KMT2A (0.44) ALDH1A1KMT2AGAACYP1A2CYP2D6
SCHEMBL5327849 0.79 CDK2 (0.56) ALDH1A1L3MBTL1KMT2APOLBMEN1
SCHEMBL6488744 0.79 MAPT (0.49) LMNAPOLBCDK2NPC1MAPT
SCHEMBL3352674 0.78 CDK2 (0.44) ALDH1A1L3MBTL1KMT2APOLBMEN1
SCHEMBL1559389 0.77 KMT2A (0.65) ALDH1A1KMT2ALMNAPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 — — EP disclosed
Send feedback